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Abstract 1 
Cell culture models are used widely to study the effects of dengue virus (DENV) 2 
on host cell function. Current methods of identification of cells infected with an 3 
unmodified DENV requires fixation and permeablization of cells to allow DENV-specific 4 
antibody staining. This method does not permit imaging of viable cells over time. In this 5 
report, a plasmid-based reporter was developed to allow non-destructive identification of 6 
DENV-infected cells. The plasmid-based reporter was demonstrated to be broadly 7 
applicable to the four DENV serotypes, including low-passaged strains, and was 8 
specifically cleaved by the viral protease with minimal interference on viral production. 9 
This study reveals the potential for this novel reporter system to advance the studies of 10 
virus-host interactions during DENV infection. 11 
Keywords 12 
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1. Introduction 1 
Dengue virus (DENV) is a mosquito-borne human pathogen of global medical 2 
importance (Bhatt et al., 2013; Simmons et al., 2012). DENV causes an acute febrile 3 
illness that, in some patients, is associated with a life-threatening plasma leakage 4 
syndrome, dengue hemorrhagic fever (DHF) (Anonymous, 2009). While there is ongoing 5 
debate regarding the contribution of different mechanisms in dengue illness, there is 6 
substantial evidence supporting both viral and host factors in disease pathogenesis. 7 
Most models propose a cascade involving systemic infection of cells of the myeloid cell 8 
lineage and cytokine production through both direct (infected cells) and indirect 9 
(bystander and immune cells) pathways (Halstead et al., 2010; Rothman, 2010; 10 
Whitehorn and Farrar, 2010). There is ongoing scientific need and interest in examining 11 
the direct effects of DENV infection on cellular metabolic processes and gene 12 
expression, which will give insight into the initial events that may impact disease 13 
severity. 14 
Given the limitations of clinical studies and existing animal models, cell culture 15 
models remain an important approach to studying DENV infection and host responses 16 
(Becerra et al., 2009; Chase et al., 2011; Heaton and Randall, 2010; Hibberd et al., 17 
2006; Pena and Harris, 2012; Ramirez-Ortiz et al., 2006). These studies have involved 18 
both continuous cell lines and primary cells from human and arthropod hosts. The 19 
analysis of host cell responses to infection has been accomplished through imaging, 20 
immunoassays, and RT-PCR. These methods are subject to at least two technical 21 
limitations- difficulty in discriminating infected and uninfected cells in the same culture, 22 
and collection of static data from individual time points. Detection of individual DENV-23 
infected cells generally relies on immunostaining. Because most DENV proteins are not 24 
expressed on the cell surface, sensitive detection of infected cells requires fixation and 25 
permeabilization of the cells, an approach that is incompatible with ongoing observation 26 
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of living cells and potentially introduces artifactual changes in cellular ultrastructure.One 1 
approach to investigate early events during DENV infection in living cells used virus 2 
labeled with a lipophilic fluorescent probe that fluoresces upon viral fusion with 3 
membranes of acidified vesicles.  This approach is limited to analysis of events prior to 4 
viral fusion (van der Schaar et al., 2008; van der Schaar et al., 2007). Several groups 5 
have reported recently the construction of DENV replicons or infectious viruses that 6 
encode reporter molecules such as luciferase or GFP (Leardkamolkarn and Sirigulpanit, 7 
2012; Leardkamolkarn et al., 2012; Mattia et al., 2011; Schoggins et al., 2012; Yang et 8 
al., 2013; Zou et al., 2011). These constructs can effectively label cells infected with the 9 
engineered virus or replicon. However, recombinant modified DENV genomes are 10 
invariably attenuated in comparison to wild-type DENV, which is likely to complicate the 11 
interpretation of virus-host interactions. Furthermore, these strategies will require further 12 
extensive manipulation to permit the study of other DENV variants, limiting the 13 
generalizability of the findings. 14 
To facilitate studies of live cells infected with DENV, a novel plasmid-based 15 
reporter, p4B5-EGFP, was created that utilize the viral protease cleavage site resulting 16 
in nuclear localization of GFP in DENV-infected cells.  The 4B5-EGFP reporter was 17 
shown to be effective in detecting infection of cells by all four DENV serotypes, including 18 
low-passaged viral strains. The results demonstrate the capability of the 4B5-EGFP 19 
reporter to identify DENV-infected cells without destruction of the cell. 20 
2. Materials and Methods 21 
2.1. Cell lines and virus 22 
Vero cells were obtained from the ATCC and maintained in Dulbecco’s 23 
Modification of Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum, 24 
100 U/ml penicillin and 100 U/ml streptomycin, with cell media also containing 25 
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nonessential amino acid (1X, HyClone). Cells were incubated in a humidified chamber at 1 
37 °C and 5% CO2. 2 
Prototype DENV strains DENV-1 Hawaii, DENV-2 16681, DENV-2 New Guinea 3 
C (NGC), DENV-3 CH53489, and DENV-4 814669 were originally obtained from the 4 
American Type Culture Collection and the Walter Reed Army Institute of Research, and 5 
were passaged multiple times in C6/36 cells (ATCC, USA). Low passaged DENV-2 6 
strains C0102/96 and C0112/96 were isolated from plasma collected in 1996 as part of a 7 
prospective study (Vaughn et al., 2000); these viruses were initially isolated by 8 
intrathoracic injection of Toxorhynchites splendens mosquitoes and then passaged up to 9 
4 times in C6/36 cells. Virus titers were determined by immunostained plaque assay on 10 
Vero cells based on the method of Liu et al with minor modifications (Liu et al., 2012). 11 
Briefly, Vero cells (1×105 cells in 50 µl/well) were added to replicate wells of 96-well 12 
white-bottom plates with 50 µl of serial 0.5 log dilutions of virus. Plates were incubated 13 
for 2 h and then 100 µl of overlay containing 1% carboxymethylcellulose was added. 14 
Plates were stained after 3 d incubation using anti-DENV antibody MAB8705 (EMD 15 
Millipore, Billerica, MA, 1:1000), horseradish peroxidase-conjugated anti-mouse Ig 16 
(Southern Biotech, 1:2000), and TMB substrate (Mabtech, Cincinnati, OH). Stained 17 
regions were read using an ELISpot plate reader to give focus-forming units per ml 18 
(ffu/ml).  The ffu/ml was log transformed and graphed using Graph Pad Prism 6.0 19 
software.  20 
2.2. Construction of the DENV reporter plasmid 21 
The DENV reporter plasmid, p4B5-EGFP, was constructed to encode the full-22 
length DENV-2 NS4B protein (without sequences encoding the 2k peptide) and the first 23 
10 amino acids of the DENV-2 NS5 protein fused to the SV40 nuclear localization signal 24 
sequence (NLS, PKKKRKVG (Cressman et al., 2001)) and the enhanced GFP (EGFP) 25 
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protein in the pcDNA3.1 vector (Life Technologies, Grand Island, NY). The primers used 1 
for PCR synthesis are shown in Table 1. The DENV sequences were originally amplified 2 
from a DENV-2 NGC infectious clone, which was kindly provided by Dr. Barry Falgout 3 
(Polo et al., 1997). A plasmid generated in our lab containing DENV-2 sequences from 4 
nucleotides 6757 to 7599, which includes NS4B and the first 30 nucleotides of NS5, was 5 
used to insert the SV40 NLS and GFP sequences downstream of the NS4B-5 cleavage 6 
site.  Briefly, to generate a fragment containing the SV40 NLS upstream of GFP, a 7 
forward primer ‘NLSGFP-EcoRI’ that incorporated a 5’ EcoRI restriction site and the 8 
SV40 NLS sequence and the reverse primer ‘GFP XhoI’ that contained a 3’XhoI 9 
restriction site were used to amplify from the pTRE-eGFP plasmid (Clontech) by PCR. 10 
The PCR fragment was digested with EcoRI and XhoI, gel purified, and ligated into the 11 
vector downstream of nucleotide 7599. To generate the p4B5-EGFP, the ‘NS4B HindIII’ 12 
forward primer and the ‘GFP XhoI’ reverse primer was used to amplify the reporter 13 
sequence by PCR.  The product of the PCR reaction and pcDNA 3.1 (Life Technologies, 14 
Grand Island, NY) were then digested with HindIII and XhoI, gel purified and ligated 15 
together. The identities of the clones were confirmed by DNA sequencing. 16 
The plasmid pNS2B3 expressing the DENV-2 NS2B3 protease was constructed 17 
using DENV-2 NGC RNA as a template. Sense and antisense primers (Table 1) were 18 
designed to generate a cDNA fragment encompassing nucleotides 4132 to 6375 of 19 
DENV-2 NGC using SuperScript® One-Step RT-PCR for long templates (Life 20 
Technologies, Grand Island, NY). The PCR fragment and the pcDNA3.1 V5-His vector 21 
(Life Technologies, Grand Island, NY) were digested with HindIII and XbaI, gel purified 22 
and ligated together. The identities of the clones were confirmed by DNA sequencing. 23 
2.3. Transfection and DENV infection 24 
Vero cells were transfected using GeneJuice® Transfection Reagent (EMD 25 
Millipore, Billerica, MA) following the manufacturer’s instructions.  Briefly, cells were 26 
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seeded in an 8-chambered Nunc Lab-Tek slide (Thermo Fisher Scientific, Rockford, IL) 1 
with a glass coverslip bottom at 2×104 cells per well 24 hrs prior to transfection.  For 2 
transfection, 1.2 µl of GeneJuice® Transfection Reagent was diluted in 15µl serum-free 3 
media and incubated at room temperature for 5 minutes, and then 0.55µg of plasmid 4 
were added to the diluted GeneJuice® Transfection Reagent and incubated for 15 5 
minutes at room temperature. The complex was then added to the cells. Vero cells were 6 
infected with DENV at a multiplicity of infection of 1 as previously described (Medin and 7 
Rothman, 2006). 8 
For cotransfection with p4B5-EGFP and pNS2B3, Vero cells were transfected 9 
with 22.5µg of each plasmid. 10 
2.4. Western Blot 11 
Whole cell extracts were prepared using lysis buffer (10% glycerol, 20 mM Tris 12 
(pH 7), 150 mM NaCl, 0.5 mM EDTA, 1% Nonidet P-40) freshly supplemented with a 13 
protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and 25 U of the Pierce 14 
Universal Nuclease (Thermo Fisher Scientific, Rockford, IL). Cells were placed on ice for 15 
15 min and centrifuged for 15 min at 14,000 rpm. Protein concentrations were 16 
determined using Bradford reagent in the Envision plate reader (Perkin Elmer, Waltham, 17 
Massachusetts) using bovine serum albumin as a standard. 15µg of protein were 18 
separated using a 12% SDS-PAGE precast gel (Biorad, Hercules, CA) and then 19 
transferred onto nitrocellulose membranes using the Trans-Blot® Turbo™ Transfer 20 
System (Biorad, Hercules, CA). Blots were blocked with 5% skim milk and subjected to 21 
immunoblot analysis using anti-GFP (Thermo Fisher Scientific, Rockford, IL, cat. 22169) 22 
diluted 1:3000 and anti-β-actin (Abcam, Cambridge, MA, cat. 8226) diluted 1:5000 23 
antibodies as indicated in the figure legends. 24 
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2.5. Staining and immunofluorescence microscopy 1 
In experiments analyzing nuclear localization of GFP, nuclear DNA was stained 2 
immediately prior to imaging with NucBlue™ Live Cell Stain or NucBlue™ Fixed Cell 3 
Stain following the manufacturer’s protocol (Life Technologies, Grand Island, NY). For 4 
detection of ER membranes, cells were washed with 1X DPBS and stained with 500nM 5 
ER-Tracker Blue-White DPX solution (Life Techonologies, Grand Island, NY) for 30 6 
minutes following the manufacturer’s protocol. Staining solution was replaced with cell 7 
culture media and immediately imaged by fluorescence microscopy using a DAPI filter.  8 
Fluorescence images were obtained using an EVOS® fl digital inverted 9 
fluorescence microscope (Advanced Microscopy Group, USA). To obtain a time series of 10 
images of nuclear localization of GFP after DENV infection, Vero cells transfected with 11 
p4B5-EGFP were infected with DENV-2 16681. The wells were washed after two hours 12 
and fresh media was added to each well. The plate was placed into Cytation3 Cell 13 
Imager (Biotek, Winooski, VT) that contains a temperature and CO2 controlled chamber. 14 
The images were acquired every 45 minutes starting at 4 h after adding virus to the cell 15 
culture using a 20x objective. 16 
Individual cells were analyzed for total cellular and nuclear GFP fluorescence 17 
using imageJ’s Analyze and Measure function.  Nuclear and cytoplasmic GFP 18 
fluorescence was defined by setting parameters based on NucBlue staining of the 19 
nucleus. Background fluorescence was measured from three regions outside of the cell.  20 
The product of the average background and area of the cell was subtracted from the 21 
integrated density (sum of the intensity of the pixels) for both the total fluorescence and 22 
nuclear fluorescence giving a corrected fluorescence as described previously (Gavet 23 
and Pines, 2010). The ratios of nuclear to total fluorescence were calculated.   24 
Total fluorescence data were not distributed normally necessitating use of 25 
nonparametric methods. Wilcoxon-Mann-Whitney rank sum test was used to quantify 26 
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differences between groups. Data presented includes analyses of individual cells with n 1 
= 24-36 cells. All statistical analyses were performed utilizing Graph Pad Prism 6.0 2 
software. 3 
To confirm DENV infection, cells were stained for DENV antigen at 24 and 48 hrs 4 
post-infection. Cells were washed once with PBS, fixed with 4% paraformaldehyde for 5 
30 min at room temperature, and permeabilized with Cytoperm (BD Biosciences, 6 
Franklin Lakes, NJ) for 15 min at 4ºC. DENV antigen was detected by indirect 7 
immunofluorescence staining using DENV complex-specific monoclonal antibody (EMD 8 
Millipore, Billerica, MA, cat. MAB8705) diluted 1:300 as the primary antibody and 9 
allophycocyanin (APC)-conjugated goat anti-mouse immunoglobulin G antibody (BD 10 
Biosciences, Franklin Lakes, NJ, cat. 558026) diluted 1:100 as the secondary antibody. 11 
To confirm NS2B3 expression, cells were stained for NS3 at 48hrs post 12 
transfection using an anti-NS3 primary antibody (Genetex, Irvine, CA ) and APC-13 
conjugated goat anti-mouse IgG as the secondary antibody.  14 
3. Results 15 
3.1. Construction and characterization of DENV reporter plasmid 16 
The DENV reporter, p4B5-EGFP, was designed to take advantage of two events 17 
that occur during DENV infection- localization of the DENV NS4B protein to the 18 
endoplasmic reticulum (ER) and proteolytic processing of the cleavage site between 19 
NS4B and NS5 by the NS2B3 protease (Bera et al., 2007; Miller et al., 2006) (Figure 20 
1a). The processing of the cleavage site by NS2B3 is expected to release the GFP 21 
component (with the small fragment of NS5) to relocalize from the cytoplasm to the 22 
nucleus.  23 
The expression and cellular distribution of the reporter construct in living cells 24 
was first evaluated by transfecting cells with the reporter plasmid and staining with an 25 
ER membrane stain. In the absence of infection with DENV (Figure 1b), transfected cells 26 
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showed cytoplasmic green fluorescence that colocalized with the ER membrane stain, 1 
indicating ER retention of the reporter.  2 
To determine whether infection with DENV would induce proteolytic cleavage 3 
between NS4B and NS5(10) and mobilize GFP to the nucleus, cells were transfected 4 
with p4B5-EGFP and infected with DENV-2 16681. Figure 1c shows a DENV-infected 5 
Vero cell culture expressing 4B5-EGFP and stained with the nuclear dye NucBlue for 6 
live-cell labeling (Invitrogen). The two cells show different phenotypes of GFP 7 
localization at 24hrs after infection, with one cell showing cytoplasmic GFP (arrowhead) 8 
and the other cell showing nuclear GFP (arrow). Analysis of nuclear to total cellular 9 
fluorescence for individual cells at 24 h showed at least a 2.4 fold increase in infected 10 
cells when compared to uninfected cells and were significantly different (p=0.0001) 11 
(Figure 1d).  These results confirmed that GFP localized to the nucleus in infected cells. 12 
Since these images were taken on a standard fluorescence microscope, the small 13 
number of cells in the uninfected 24h condition showing an increase in fluorescence 14 
intensity was due to the fluorescence bleed from cytoplasmic region into the nuclear 15 
region.  16 
To verify cleavage of the 4B5-EGFP, Western blot analysis was performed on 17 
cell lysates using an antibody against GFP.  As seen in Figure 1e, uninfected cells 18 
transfected with p4B5-EGFP showed a single band localizing to approximately 60kD, 19 
which is the expected size of the expressed fusion protein. In cells infected with DENV-2 20 
at an m.o.i. of 1 for 24 hours, the 60kD band was reduced in intensity and a lower 30kD 21 
band appeared.  The 30kD band corresponds to the expected size of the NS5 fragment 22 
fused to eGFP. These results confirm that the 4B5-EGFP is cleaved during DENV 23 
infection.  24 
3.2. Kinetics of nuclear localization of GFP after DENV infection 25 
 11
To determine the earliest time point that the 4B5-EGFP reporter could detect 1 
DENV infection, transfected cells infected with DENV were analyzed by fluorescence 2 
microscopy.  Relocation of green fluorescence into the nucleus was seen as early as 8 h 3 
post-infection (data not shown). Time-lapse images of Vero cells in a DENV-infected 4 
culture were taken to further determine the time required to visually identify GFP 5 
movement from the cytoplasm to the nucleus (Figure 2). Movement of cytoplasmic GFP 6 
to the nucleus was visible in four of the five cells in Figure 2 by 7 h after addition of virus. 7 
One cell remained uninfected during this analysis (Figure 2, arrowhead).  Calculation of 8 
the ratio of nuclear to total fluorescence at each time point for a representative cell 9 
(Figure 2, arrow) showed successive increase in nuclear fluorescence over time. 10 
3.3. Nuclear GFP correlates with DENV antigen staining 11 
To verify that the cells displaying nuclear localization of GFP were infected with 12 
DENV, cells were fixed, permeabilized and stained using a DENV-specific monoclonal 13 
antibody. Figure 3a shows a pair of cells in a DENV-infected cell culture. The arrow 14 
shows a cell with nuclear GFP, indicating viral infection, whereas the arrowhead shows a 15 
cell with only cytoplasmic GFP, indicating no viral infection.  As seen in the third and 16 
fourth panels of Figure 3a, the bottom left cell (with nuclear GFP) stained with the anti-17 
DENV antibody whereas the upper cell (with only cytoplasmic GFP) did not. 18 
3.4. Expression of the DENV NS2B-3 protease is sufficient for cleavage of 4B5-19 
EGFP 20 
Previous reports have shown that both NS2B and NS3 are required for efficient 21 
proteolytic cleavage of the DENV polyprotein (Brinkworth et al., 1999; Falgout et al., 22 
1991). A construct that expresses DENV-2 NS2B3 was created to determine if the 23 
NS2B3 protease alone could induce nuclear localization of GFP.  Cells were transfected 24 
with the p4B5-EGFP alone or cotransfected with the NS2B3 plasmid.  As seen in Figure 25 
3b, cells transfected with p4B5-EGFP showed cytoplasmic GFP expression only. In 26 
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contrast, cells expressing NS2B3 and 4B5-EGFP showed nuclear localization of GFP 1 
(Figure 3c). In these experiments, nuclear localization was detected 48 and 72 hs post-2 
transfection.  This delay in protease activity may reflect a lower level of protease 3 
expression from the plasmid compared to DENV-infected cells.  Alternatively, NS2B3 4 
may require additional viral factors to cleave efficiently the NS4B-5 junction. 5 
3.5. DENV serotype and strain specificity of the 4B5-EGFP reporter 6 
The viral gene segment in p4B5-EGFP was derived from DENV-2 NGC, a 7 
laboratory-adapted virus originally isolated in 1944 and was tested using DENV-2 16681, 8 
another laboratory-adapted virus that was isolated in 1964 (Vaughn et al., 1996).  Each 9 
DENV serotype can be subdivided into specific genotypes, which can have up to 6% 10 
genetic divergence (Rico-Hesse, 1990; Twiddy et al., 2002). To assess whether the 11 
construct would be processed by other DENV-2 strains, low passaged recent clinical 12 
isolates were used to infect cells. Transfected cells were infected with two viral isolates, 13 
C0102/96 and C0112/96, which were originally isolated from the plasma of patients with 14 
dengue in 1996. Nuclear localization of GFP and DENV antigen staining was analyzed 15 
at 24 hours post-infection. As seen with DENV-2 16681, DENV antigen staining 16 
correlated with nuclear GFP for both C0102/96 (data not shown) and C0112/96 (Figure 17 
4b).  18 
The four serotypes of DENV have up to 70% sequence homology across their 19 
genomes (Blok, 1985).  Previous reports have shown that the DENV protease is less 20 
selective than the proteases of other flaviviruses and can tolerate amino acid changes 21 
within the cleavage site (Shiryaev et al., 2007). Additionally, the NS2B3 protease 22 
cleaves at least five sites with little sequence homology within the same DENV 23 
polyprotein (Bera et al., 2007). Therefore, to analyze whether this reporter plasmid could 24 
be used to detect infection with other DENV serotypes, cells transfected with the reporter 25 
plasmid were infected with each of the four DENV serotypes. For all four serotypes, 26 
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nuclear localization of GFP was detected at 24 hours post-infection (Figure 4). The 1 
specificity of nuclear GFP for DENV-infected cells was verified by co-staining for DENV 2 
antigen (red).  3 
3.6. Effects of 4B5-EGFP on DENV replication  4 
Full length NS4B contains a cleavable 2K signal peptide at the N terminus, and 5 
has been shown to be required for IFN antagonism (Munoz-Jordan et al., 2005). The 6 
NS4B in the pNS4B5-EGFP was designed to be expressed without the 2K region and 7 
therefore, should have no effect on inhibiting the antiviral response. To determine 8 
whether transfection of the p4B5-EGFP had an effect on viral production compared to 9 
untransfected cells, viral titers in supernatants of DENV-infected Vero cells transfected 10 
with p4B5-EGFP or a control plasmid, pTracer, expressing GFP alone were assessed by 11 
plaque assay.  Viral titers in virally infected cells without transfection were compared to 12 
cells that were transfected. Since Vero cells do not have an intact innate immune system 13 
(Mosca and Pitha, 1986), parallel experiments with CV-1 cells, which do elicit an innate 14 
immune response to dsRNA was also performed (Thacore et al., 1990). Cells 15 
transfected with pNS4B5-EGFP and pTracer showed a 3 to 7-fold reduction in viral titers 16 
when compared to infected cells that were untransfected depending on the serotype 17 
used for infection (Figure 5).  There were minimal differences in viral titers between cells 18 
transfected with either the control plasmid or cells transfected with p4B5-EGFP. These 19 
results indicate that transfection alone reduced viral titers. Additionally, cells transfected 20 
with p4B5-EGFP and pTracer were comparable at both 24 and 48h post-infection in both 21 
Vero and CV-1 cells indicating that the reporter did not affect viral replication (data not 22 
shown). 23 
4. Discussion 24 
In the present study, a DENV-specific plasmid-based reporter system, 4B5-25 
EGFP, was characterized for detection of infected cells in live cell culture for all four 26 
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DENV serotypes. Although systems for analyzing DENV replication in culture have 1 
expanded in recent years, detection methods applicable to imaging and detection of 2 
cells infected with native viral isolates in unfixed cells have not been available. The 4B5-3 
EGFP reporter does not require genetic modification of the viral genome. 4 
The 4B5-EGFP reporter also showed detection of cellular infection with each of 5 
the DENV serotypes. Previous reports have analyzed sequence variation within the 6 
NS4B-NS5 junction between various flaviviruses (Bera et al., 2007; Lin et al., 1993; 7 
Shiryaev et al., 2007).  The amino acids in the P1, P2 and P1’ positions are similar for all 8 
four DENV serotypes as well as Yellow Fever virus, however, amino acids occupying P2’ 9 
and P3’ are different (Shiryaev et al., 2007). Those experiments were done with 10 
synthetically produced peptides; the role of surrounding amino acids and membrane 11 
tethering of the proteins may be an additional factor in the selectivity of trans cleavage 12 
by flaviviral proteases (Clum et al., 1997). Further analysis using other flaviviruses would 13 
be useful to establish the specificity of this reporter system.  14 
The advantage of using the 4B5-EGFP reporter the detection of GFP can be 15 
carried out with fluorescence microscopy. Additionally, the ability to monitor infection by 16 
fluorescence relocalization in living cells also suggests the possibility of continuous 17 
visualization of DENV infection.  The 4B5-EGFP reporter was proteolytically processed 18 
as early as 8 hrs post-infection, which correlates with synthesis of new viral protein 19 
(Shrivastava et al., 2011). The ability to detect viral infection during initial translation of 20 
the viral genome will extend analysis of cellular events to early time points.  21 
Numerous studies have demonstrated that in vitro infection with DENV induces 22 
significant changes in cellular gene expression and metabolic processes (Becerra et al., 23 
2009; Chase et al., 2011; Heaton and Randall, 2010; Hibberd et al., 2006; Pena and 24 
Harris, 2012; Ramirez-Ortiz et al., 2006). The experiments conducted in those studies 25 
processed unsorted cultures of cells exposed to DENV. Therefore, the effects measured 26 
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in those studies reflect both direct effects of viral infection on the infected cell as well as 1 
secondary effects on both infected and uninfected cells in the same culture (Nightingale 2 
et al., 2008; Palmer et al., 2005). The 4B5-EGFP reporter in this study has the potential 3 
to identify effects on individually infected and uninfected cells within the same culture.  4 
Live-cell analysis of virus-infected cells by fluorescence microscopy represents a 5 
promising approach to investigate virus-cell interactions (Coller et al., 2012; Jones et al., 6 
2010; Lee-Huang et al., 2011; Paloheimo et al., 2011; Rand et al., 2012; Sivaraman et 7 
al., 2011; van der Schaar et al., 2008; van der Schaar et al., 2007). This approach has 8 
been used for other viruses to study virion entry and assembly and the dynamics of 9 
movement of viral proteins and cell structures within the infected cell. For several 10 
viruses, live cell imaging has revealed new mechanisms critical to viral replication or cell-11 
to-cell spread and has been used for antiviral drug screening. 12 
 A theoretical concern with this approach was that the DENV protein segment 13 
expressed by the plasmid might itself affect cellular function. For example, DENV NS4B 14 
has been reported to inhibit type I IFN signaling (Munoz-Jordan et al., 2003). Munoz-15 
Jordan et al reported, however, that deletion of the N-terminal 2K segment eliminated 16 
the inhibition of IFN without affecting ER localization (Munoz-Jordan et al., 2005). The 17 
4B5-EGFP reporter plasmid did not contain the 2K segment, and, consistent with the 18 
published results, was not different from a control plasmid in its effects on DENV 19 
replication. Viral replication was lower in transfected cells than in untransfected cells, 20 
likely due at least in part to induction of type I IFN (Park et al., 2003). A cell line stably 21 
transfected with the 4B5-EGFP reporter would be expected to overcome this limitation. 22 
The reagents developed in this project have some limitations for other types of 23 
analyses. To this effect the 4B5-EGFP transfected cells fluoresce green regardless of 24 
infection status, therefore the cells are not amenable to cell sorting for downstream 25 
analyses. Since eGFP is a commonly used fluorescence molecule, exchanging eGFP for 26 
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a less commonly used color such as BFP or YFP will permit multicolor fluorescence 1 
target analyses. Additionally, there are potential applications of the 4B5-EGFP reporter 2 
in drug screening and the development of novel animal or cell culture models of DENV 3 
infection.  4 
The 4B5-EGFP reporter described is a promising strategy for identifying live 5 
DENV-infected cells by fluorescence microscopy. Potential applications of the 4B5-6 
EGFP reporter include identifying infectious virus directly from patient samples. To this 7 
effect, nuclear GFP was seen in transfected cell cultures infected with low-passaged 8 
isolates.  9 
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TABLE 1. Oligonucleotide primers used for PCR amplification. 1 
Oligonucleotide Sequencea 
NS4B HindIII F 
5'-
CATTGGCAAAGCTTGCCACCATGGCGAACGAGATGGGTTTCCTAGAAAAAACGAAG-
3' 
NS5(10aa) EcoRI R 5'-CATTTCTCGAATTCTCCAAGCGTCTCTCCTATGTTGCCAGTTCCCCTTC-3' 
SV40NLS-eGFP 
EcoRI F 
5'-
CGCGGAATTCGCCACCATGCCGAAGAAAAAGCGGAAGGTTGGCGTGAGCAAGGGC
GAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGT-3' 
eGFP XhoI R 5'-CGCGCTGCCTCGAGTTACTTGTACAGCTCGTCCATGCCGAGAGTGATC-3' 
NS2B3 HindIII F 5'-CAAGAAAAGGAAGCTTGCCACCATGAGCTGGCCATTAAATGAGGCTATCATG-3' 
NS2B3 XbaI R 5'-GGTCAGAGATCTAGACTTTCTTCCGGCTGCAAATTC-3' 
a
 underlined text = the Kozak sequence, bold text = restriction endonuclease, italics = SV40 NLS 
 2 
Figure Legends 3 
Figure 1. Construction and characterization of p4B5-EGFP. 4 
(a) Schematic of the p4B5-EGFP construct containing NS4B and the first 30 5 
nucleotides of NS5 of the DENV-2 genome tagged with the SV40 NLS and 6 
eGFP. The arrow indicates the cleavage site utilized by the DENV NS2B3 7 
protease. The vertical lines represent restriction endonuclease sites. 8 
(b) Unfixed Vero cells transfected with p4B5-EGFP were stained with ER-Tracker 9 
Blue-White DPX dye (Cyan) 24hrs post-transfection and immediately imaged to 10 
detect colocalization of NS4B5-EGFP (reporter, green) with ER membranes 11 
(blue, magnification, x100). Inset reflects ER staining of cells alone. (c) Unfixed 12 
Vero cells transfected with p4B5-EGFP were infected with DENV-2 16681. Nuclei 13 
were counterstained with NucBlue for live cells (Invitrogen) (blue) to detect 14 
nuclear localization of GFP (green, magnification, x100). Cytoplasmic expression 15 
of GFP is indicated by the arrowhead and nuclear expression of GFP is indicated 16 
by an arrow (magnification, x100). (d) Analysis of nuclear to total fluorescence 17 
intensity ratios of GFP (nuclear:total fl) in uninfected and DENV infected cells at 18 
 25
24 h was performed using ImageJ software.  Each symbol represents analysis of 1 
a single cell.  Statistical analysis was performed using nonparametric Wilcoxon-2 
Mann-Whitney rank sum test. Straight line represents the median. (e) Cellular 3 
lysates were prepared 24 h post infection and subjected to Western blotting for 4 
GFP or β-actin. The 5-EGFP fragment represents the cleavage product resulting 5 
from cleavage between NS4B and NS5-EGFP during viral infection. 6 
 7 
Figure 2. Kinetics of nuclear localization of GFP after DENV infection. Vero cells 8 
transfected with p4B5-EGFP were infected with DENV-2 16681 and sequential 9 
images were acquired to assess the time for GFP to localize into the nucleus. 10 
Each set of images shows the expression of GFP in p4B5-EGFP transfected 11 
cells (top row), nuclear stain using NucBlue (middle row) and transmitted images 12 
(bottom row) at each time point. Time after addition of virus to the culture is 13 
located at the lower left of each image (magnification, x20). Nuclear/total 14 
fluorescence (N/T) was calculated at each time point for a representative cell 15 
(arrow). The arrowhead shows a cell that remains uninfected over time. Data are 16 
representative of at least five experiments. 17 
 18 
Figure 3. Nuclear localization of GFP correlates with DENV antigen and co-19 
expression of the NS2B3 protease. (a) Vero cells were transfected with p4B5-20 
EGFP (green) and infected with DENV-2 16681 at an m.o.i of 1.  24 hours post-21 
infection, cells were fixed, permeabilized and stained with antibody against 22 
DENV complex. The NS4B5-EGFP panel shows cytoplasmic expression of GFP 23 
 26
(right, arrow neighboring cytoplasmic and nuclear expression of GFP (left, 1 
arrowhead) (magnification, x100). DENV Ag panel shows DENV antigen staining 2 
in cells infected with DENV. Overlay of GFP and antigen staining (red) shows that 3 
nuclear localization of GFP correlates with DENV antigen staining (magnification, 4 
x100). (b and c) Vero cells transfected with the p4B5-EGFP alone (b) or 5 
cotransfected with pNS2B3 (c) were analyzed for nuclear localization of GFP at 6 
48hrs post-transfection (magnification, x100). NS4B5-EGFP panel shows 7 
location of GFP within the cells (green). The nucleus panel shows the nucleus 8 
stained with NucBlue (blue, Life Technologies). The NS2B3 panel shows indirect 9 
antibody staining for NS3 (red). The overlay shows that nuclear GFP expression 10 
correlates with NS2B3 expression. Data are representative of at least six (a) and 11 
two (b) experiments. 12 
 13 
Figure 4. All four DENV serotypes induce cleavage of p4B5-EGFP to localize 14 
GFP to the nucleus.  Vero cells transfected with p4B5-EGFP (green) were 15 
infected with each of the four DENV serotypes at an MOI of 1.  Cells were fixed, 16 
permeabilized and stained for DENV antigen (red) and nuclear DNA (cyan). Cells 17 
were analyzed at 24 hours post-infection by fluorescence microscopy.  Each row 18 
is a representative image of DENV infected cells in bright field (trans) and 19 
fluorescence images showing nuclear stain (cyan), DENV antigen stain (red), 20 
4B5-EGFP expression (green). The overlay is a composite of the nucleus, DENV 21 
and NS4B-EGFP images. (a) DENV-1 Hawaii, (b) DENV-2 C0112/96, (c) DENV-3 22 
 27
CH53489 and (d) DENV-4 814669. Data are representative of at least four 1 
experiments each. 2 
 3 
Figure 5. Expression of 4B5-EGFP reporter has minimal effects on DENV 4 
replication. 5 
Vero cells were transfected with pTracer or p4B5-EGFP or untransfected and 6 
infected at an m.o.i. of 1 with DENV 24h later.  After 24 h supernatants were 7 
collected for viral titration. Each time point represents the geometric mean and 8 
95% confidence interval (CI) of six experiments. 9 
 10 
